Yahoo Web Search

Search results

1. • 

     What are the latest developments in breast cancer treatment? Central Mass. experts explain

     Worcester Telegram & Gazette via Yahoo News· 7 months ago

     WORCESTER — October is Breast Cancer Awareness Month, and the rate of breast cancer incidence for...

2. • 

     Perspective: ‘Without this bill, I will die’

     Deseret News via Yahoo News· 3 months ago

     Carrie Ann Kemp poses for a portrait at home in Provo on Tuesday, Feb. 13, 2024. Kemp’s cancer medication costs $24,000 a month. | Kristin Murphy,...

3. • 

     Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation

     Reuters via Yahoo Finance· 1 year ago

     The blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...

4. • 

     Pfizer, looking for a jumpstart, leans into cancer drug research

     BioPharma Dive via Yahoo Finance· 2 months ago

     Pfizer believes the answer to its sliding valuation lies in oncology. The company, which is coming...

5. • 

     Pfizer to sell all its patented drugs at nonprofit price in low-income countries

     Reuters via Yahoo Finance· 2 years ago

     Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and...

6. • 

     Which drugs will be selected for Medicare negotiations? Here’s what we know

     The Hill via Yahoo News· 10 months ago

     The first 10 drugs selected for Medicare price negotiation will be announced by Sep. 1 and will set...

7. • 

     Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

     Motley Fool via Yahoo Finance· 2 weeks ago

     Pfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...

8. • 

     Pfizer Stock Wavers As Waning Demand For Covid Products Slashes Sales In Half

     Investor's Business Daily· 9 months ago

     Declining demand for Covid products slammed Pfizer results in the second quarter. Pfizer stock...

9. • 

     Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'

     Reuters via Yahoo News· 1 year ago

     NEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug...

10. • 

      2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now

      Motley Fool via Yahoo Finance· 4 months ago

      Does a rising tide lift all boats? Not always. The S&P 500 is now officially in a new bull market,...